Skip to content

E-pot Study: EnSite & Pressure- Volume in Cardiac Resynchronization Therapy, a multicenter, prospective, feasability, non-randomized pilot study

E-pot Study: EnSite & Pressure- Volume in Cardiac Resynchronization Therapy, a multicenter, prospective, feasability, non-randomized pilot study - E-pot study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32196
Enrollment
30
Registered
2008-11-18
Start date
2008-06-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiomyopathy Heart Failure

Interventions

None listed

Sponsors

St. Jude Medical
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • CRT-D conventional indication • QRS width > 120 ms • Left Ventricular Ejection Fraction (LVEF)

Exclusion criteria

Exclusion criteria: • History of chronic AF • MI within the last 3 Months • Previous pacemaker or ICD implanted • Claudication intermittens or other significant arterial vein issues in the aortic-iliac route • Moderate to severe aortic valve stenosis or indication for valve surgery or mechanical aortic valve replacement or thrombus in Left Ventricle • Age 80 years • Heart failure NYHA class IV • Serious comorbidity such as cancer, with a likelihood of death during the study • Unwilling or unable to sign the consent form for participation • Females of childbearing age not using medically prescribed contraceptives

Design outcomes

Primary

MeasureTime frame
Optimal position of the lead is defined as the one providing optimal acute hemodynamics (defined by the highest Stroke Volume as measured by Pressure-Volume recordings compared to Atrial paced-Ventricle sensed pacing configuration)

Secondary

MeasureTime frame
1. Assessment of the correlation between the electrical activation pattern and Stroke Work. 2. Assessment of the correlation between mechanical delay and electrical delay. The mechanical (resp. electrical) delay will be defined as the maximum delay between the first and the last contracted (resp. activated) area. 3. Assessment of correlation between scar tissue areas and the latest electrical and mechanical activated areas 4. Assessment of correlation between dp/dt & volumes (PV loops recordings) and optimal position of pacing wire 5. Assessment of electrical parameters: correlation between QRS width and electrical activation patterns

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)